Department of Otolaryngology/Head and Neck Surgery, St. Lucas Andreas Hospital, Jan Tooropstraat 164, Amsterdam, 1061 AE, The Netherlands.
Eur Arch Otorhinolaryngol. 2011 Apr;268(4):631-5. doi: 10.1007/s00405-010-1419-4. Epub 2010 Nov 18.
The objectives of the study are to assess adverse events and complications of hyoid suspension (HS) as a treatment of obstructive sleep apnea syndrome (OSAS). The study design was cohort. Thirty-nine patients with OSAS and obstruction at tongue base level, as assessed by sleep endoscopy, underwent HS. Information about adverse events and complications were obtained by reviewing charts and patient-completed questionnaires. The mean follow-up period from surgery to last control visit was 13.1 months (range 2-38). The charts demonstrated mainly adverse events. Minor complications occurred in six patients. No major complications were observed. The mean admission duration was 3.3 days (range 2-5). Twenty-six patients (67%) returned their questionnaires. No association was found between completing questionnaires and the success of the intervention (p = 0.73). The questionnaires were completed on average 25.9 months (range 3.5-51.5) after surgery. VAS scores showed a fast decline in complaints regarding taste, speech, swallowing and pain. No significant long-term differences were found, when comparing the postoperative VAS scores with the preoperative VAS scores. Of the 26 evaluable questionnaires, 20 patients (77%) would recommend HS to an acquaintance if they suffered from sleep apnea syndrome, when only taking side effects into consideration. The intention to give a positive recommendation did not seem to be related to the therapeutic success of the intervention. In conclusion, this study demonstrates that the complication rate of HS is low and that the discomfort is very acceptable.
本研究的目的是评估悬雍垂提升术(HS)治疗阻塞性睡眠呼吸暂停综合征(OSAS)的不良事件和并发症。研究设计为队列研究。39 例经睡眠内镜评估舌根水平存在阻塞的 OSAS 患者接受了 HS。通过查阅病历和患者完成的问卷,获取有关不良事件和并发症的信息。从手术到最后一次随访的平均随访时间为 13.1 个月(范围 2-38)。病历主要显示不良事件。6 例患者出现轻微并发症。未观察到严重并发症。平均住院时间为 3.3 天(范围 2-5)。26 例患者(67%)返回了问卷。完成问卷与干预的成功之间没有相关性(p=0.73)。问卷平均在手术后 25.9 个月(范围 3.5-51.5)完成。VAS 评分显示味觉、言语、吞咽和疼痛等方面的抱怨迅速下降。与术前 VAS 评分相比,术后 VAS 评分无明显长期差异。在 26 份可评估的问卷中,20 名患者(77%)如果患有睡眠呼吸暂停综合征,仅考虑副作用,会向熟人推荐 HS。积极推荐的意愿似乎与干预的治疗效果无关。总之,本研究表明 HS 的并发症发生率较低,且不适感可接受。